417 related articles for article (PubMed ID: 19301711)
1. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
Ogbolu DO; Ogunledun A; Adebiyi OE; Daini OA; Alli AO
Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic disc sensitivity pattern of pseudomonas aeruginosa isolates obtained from clinical specimens in Ilorin, Nigeria.
Fadeyi A; Akanbi AA; Nwabuisi C; Onile BA
Afr J Med Med Sci; 2005 Sep; 34(3):303-6. PubMed ID: 16749366
[TBL] [Abstract][Full Text] [Related]
4. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
[TBL] [Abstract][Full Text] [Related]
5. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
[TBL] [Abstract][Full Text] [Related]
7. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
Al-Jasser AM; Elkhizzi NA
Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
[TBL] [Abstract][Full Text] [Related]
9. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
11. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
12. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.
Hsueh PR; Tseng SP; Teng LJ; Ho SW
Clin Microbiol Infect; 2005 Aug; 11(8):670-3. PubMed ID: 16008621
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan.
Ullah F; Malik SA; Ahmed J
Burns; 2009 Nov; 35(7):1020-5. PubMed ID: 19501980
[TBL] [Abstract][Full Text] [Related]
14. Changes in the rates of antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa between 2002 and 2004 in a tertiary-care teaching hospital in Turkey.
Işeri L; Bayraktar MR
New Microbiol; 2008 Jul; 31(3):351-5. PubMed ID: 18843889
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin-resistant Pseudomonas keratitis.
Garg P; Sharma S; Rao GN
Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
[TBL] [Abstract][Full Text] [Related]
17. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.
Friedland I; Gallagher G; King T; Woods GL
J Chemother; 2004 Oct; 16(5):437-41. PubMed ID: 15565908
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
Minchella A; Molinari L; Alonso S; Bouziges N; Sotto A; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
